Results 111 to 120 of about 51,251 (187)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. [PDF]

open access: yes, 2015
ObjectiveTofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). The pathways affected by tofacitinib and the effects on gene expression in situ are unknown.
Boyle, DL   +14 more
core  

Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.

open access: yesBlood, 2021
Chang Y   +26 more
europepmc   +1 more source

Janus kinase

open access: yes, 2019
Yuranga Weerakkody   +2 more
openaire   +1 more source

STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts. [PDF]

open access: yesCell Rep
Dennaoui R   +10 more
europepmc   +1 more source

FDA-approved small-molecule kinase inhibitors [PDF]

open access: yes, 2015
Clausen, Mads Hartvig   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy